Arlington Partners
$55M 13F equity value
64 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Arlington Partners covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| VEA | Vanguard FTSE Developed Markets ETF | 298,007 | $21M | 38.4% |
| VGSH | Vanguard Short-Term Government Bond Index Fund ETF | 225,571 | $13M | 23.7% |
| PSBD | Palmer Square Capital BDC Inc | 510,344 | $5M | 9.6% |
| AQEC | AQE Core ETF | 32,191 | $768,496 | 1.4% |
| NVO | Novo Nordisk A/S Spons Adr | 6,777 | $324,889 | 0.6% |
| HD | Home Depot Inc | 887 | $312,827 | 0.6% |
| TMO | Thermo Fisher Scientific Inc | 618 | $309,840 | 0.6% |
| ASML | ASML Holding NV ADR | 154 | $306,374 | 0.6% |
| AJG | Arthur J Gallagher & Co | 1,324 | $303,951 | 0.5% |
| AON | Aon PLC | 887 | $294,209 | 0.5% |
Track Arlington Partners's 13F portfolio: $55M in reported holdings, 64 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}